Drug Type Small molecule drug |
Synonyms EG-009, EG-009A, EG-HPCP-03A |
Target |
Mechanism GR modulators(Glucocorticoid receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cytokine Release Syndrome | Phase 2 | CN | 30 Jan 2023 | |
COVID-19 | Phase 2 | - | 04 Mar 2022 |